A randomized trial of induction doses of interferon alone or in combination with ribavirin or ribavirin plus amantadine for treatment of nonresponder patients with chronic hepatitis C

By Gramenzi Annagiulia   Andreone Pietro   Cursaro Carmela   Verucchi Gabriella   Boccia Sergio   Giacomoni Pier Luigi   Galli Silvia   Furlini Giuliano   Biselli Maurizio   Lorenzini Stefania   Attard Luciano   Bonvicini Fiorenza   Bernardi Mauro  

Journal of Gastroenterology, Vol. 42, Iss. 5, 2007-05 ,pp. : 362-367

Springer Publishing Company

Access to resources Recommend Favorite

Retreatment with Interferon-Alpha and Ribavirin in Primary Interferon-Alpha Non-Responders with Chronic Hepatitis C

By  

Digestion, Vol. 61, Iss. 2, 2000-02 ,pp. : 90-97

Karger

Access to resources Recommend Favorite

Mutations in the interferon sensitivity determining region and virological response to combination therapy with pegylated-interferon alpha 2b plus ribavirin in patients with chronic hepatitis C-1b infection

By Nakagawa Mina   Sakamoto Naoya   Ueyama Mayumi   Mogushi Kaoru   Nagaie Satoshi   Itsui Yasuhiro   Azuma Seishin   Kakinuma Sei   Tanaka Hiroshi   Enomoto Nobuyuki   Watanabe Mamoru  

Journal of Gastroenterology, Vol. 45, Iss. 6, 2010-06 ,pp. : 656-665

Springer Publishing Company

Access to resources Recommend Favorite

Autoimmune Enteropathy Associated with Cessation of Interferon-Alpha Therapy in Chronic Hepatitis C

By Gonzalez German   Castro Fernando   Berho Mariana   Petras Robert  

Digestive Diseases and Sciences, Vol. 55, Iss. 5, 2010-05 ,pp. : 1490-1493

Springer Publishing Company

Access to resources Recommend Favorite

Direct Medical Care Costs Among Pegylated Interferon Plus Ribavirin-Treated and Untreated Chronic Hepatitis C Patients

By Solomon M.  

Digestive Diseases and Sciences, Vol. 56, Iss. 10, 2011-10 ,pp. : 3024-3031

Springer Publishing Company

Access to resources Recommend Favorite